Market News / Story
Lipocine: Health Canada approves TLANDO oral TRT, Verity Pharma to launch in Canada by end-2026
·
Lipocine announced Health Canada approval of TLANDO for testosterone replacement therapy in adult males. Key Highlights: Health Canada approved TLANDO (testosterone undecanoate) capsules for male hypogonadism; approval covers adult males with testosterone deficiency. Verity Pharma, Lipocine’s North America licensee, holds exclusive commercial rights and plans Canadian launch and commercialization by end of 2026. TLANDO offers an oral, fixed-dose option without…